[HTML][HTML] Smoking and risk of negative outcomes among COVID-19 patients: a systematic review and meta-analysis

A Umnuaypornlert, S Kanchanasurakit… - Tobacco induced …, 2021 - ncbi.nlm.nih.gov
METHODS Electronic databases, including PubMed, EMBASE, Cochrane Library, Science
Direct, Google Scholar, were systematically searched from the initiation of the database until …

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review …

M Tagliamento, E Agostinetto, M Bruzzone… - Critical reviews in …, 2021 - Elsevier
Background A systematic review and meta-analysis was performed to estimate mortality in
adult patients with solid or hematological malignancies and SARS-CoV-2 infection. Methods …

Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited

A Ribas, R Sengupta, T Locke, SK Zaidi, KM Campbell… - Cancer discovery, 2021 - AACR
Published series on COVID-19 support the notion that patients with cancer are a particularly
vulnerable population. There is a confluence of risk factors between cancer and COVID-19 …

Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US nationwide veterans affairs study

JTY Wu, J La, W Branch-Elliman, LB Huhmann… - JAMA …, 2022 - jamanetwork.com
Importance Patients with cancer are at increased risk for severe COVID-19, but it is unknown
whether SARS-CoV-2 vaccination is effective for them. Objective To determine the …

Difference in SARS-CoV-2 antibody status between patients with cancer and health care workers during the COVID-19 pandemic in Japan

S Yazaki, T Yoshida, Y Kojima, S Yagishita… - JAMA …, 2021 - jamanetwork.com
Importance Patients with cancer and health care workers (HCWs) are at high risk of SARS-
CoV-2 infection. Assessing the antibody status of patients with cancer and HCWs can help …

Learning through a pandemic: the current state of knowledge on COVID-19 and cancer

A Elkrief, JT Wu, C Jani, KT Enriquez, M Glover… - Cancer discovery, 2022 - AACR
The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

AI Yasin, SG Aydin, B Sümbül, L Koral, M Şimşek… - Future …, 2022 - Taylor & Francis
Aim: To compare the seropositivity rate of cancer patients with noncancer controls after
inactive SARS-CoV-2 vaccination and evaluate the factors affecting seropositivity. Method …

COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway

TB Johannesen, S Smeland, S Aaserud… - Frontiers in …, 2021 - frontiersin.org
Background Cancer has been suggested as a risk factor for severe outcome of SARS-CoV-2
infection. In this population-based study we aimed to identify factors associated with higher …

Knowledge and proportion of COVID-19 vaccination and associated factors among cancer patients attending public hospitals of Addis Ababa, Ethiopia, 2021: a …

F Tadele Admasu - Infection and drug resistance, 2021 - Taylor & Francis
Background Cancer patients are classified as being at high risk of contracting COVID-19
infection, hospitalization, and death and were recommended to have early access to the …

[HTML][HTML] Characterizing cancer and COVID-19 outcomes using electronic health records

Y Kim, L Zhu, H Zhu, X Li, Y Huang, C Gu, H Bush… - Plos one, 2022 - journals.plos.org
Purpose Patients with cancer often have compromised immune system which can lead to
worse COVID-19 outcomes. The purpose of this study is to assess the association between …